Pharmaceutical Executive
Pharmaceutical Executive Podcast
Add to My Podcasts
Episodes
About
Reviews
Promote
New FDA SaMD Guidance Will Bring Monumental Changes to Industry
10 minutes
Posted Oct 12, 2023 at 1:00 pm.
0:00
10:31
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
David Klein, co founder and CEO of Click Therapeutics, discusses the new FDA SaMD guidance, the clear differences between companion apps and SaMD, and gives insight into what to expect from this combination in the future.
Previous
Venture Creation Firm Reveals Strategies For Launching New Companies & Forming Collaborations
Next
DCT Opportunities in Clinical Research
← See all 489 episodes of Pharmaceutical Executive